Racial differentials in the identification of hypercholesterolemia

E H Naumburg1, P Franks, B Bell

  • 1Department of Family Medicine, University of Rochester, New York.

Insights

Racial minorities are less likely to be screened for high cholesterol and diagnosed with hypercholesterolemia compared to white Americans. This suggests disparities in healthcare provider behavior influence cardiovascular risk management.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Health Disparities Research
  • Clinical Practice Analysis

Background:

  • African Americans experience higher cardiovascular disease (CVD) rates than white Americans.
  • Identifying barriers to CVD risk reduction is crucial for addressing racial disparities.
  • This study investigates race-based differences in hypercholesterolemia screening and diagnosis.

Purpose of the Study:

  • To examine the association between patient race and the likelihood of receiving cholesterol screening.
  • To determine if race influences the diagnosis of hypercholesterolemia among screened patients.
  • To identify potential provider behavior variations contributing to CVD risk management disparities.

Main Methods:

  • Prospective data collection from a family medicine residency program (N=4256).
  • Multivariate analyses controlled for age, sex, insurance, socioeconomic status, visit frequency, and other CVD risk factors.
  • Inclusion criteria: complete data on demographics and cardiovascular risk factors.

Main Results:

  • Minorities were less likely than whites to be screened for cholesterol (adjusted odds ratio [AOR] = 0.84).
  • No significant difference in mean cholesterol levels was observed between racial groups.
  • Screened minorities were less likely to be diagnosed with hypercholesterolemia than whites (AOR = 0.62), particularly those with high cholesterol levels (AOR = 0.47).

Conclusions:

  • Provider behavior in diagnosing hypercholesterolemia appears to vary significantly by patient race.
  • These findings highlight potential racial biases in clinical decision-making impacting CVD risk management.
  • Further research is needed to address these disparities and improve equitable cardiovascular care.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...